BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33998268)

  • 1. The role of ligand-binding assay and LC-MS in the bioanalysis of complex protein and oligonucleotide therapeutics.
    Kotapati S; Deshpande M; Jashnani A; Thakkar D; Xu H; Dollinger G
    Bioanalysis; 2021 Jun; 13(11):931-954. PubMed ID: 33998268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
    Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
    Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Analytical Strategies for Antibody-Drug Conjugates in Biomatrices.
    Qin Q; Gong L
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM.
    Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI
    Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis).
    Welink J; Xu Y; Yang E; Wilson A; Henderson N; Luo L; Fraser S; Kavita U; Musuku A; James C; Fraier D; Zhang Y; Goykhman D; Summerfield S; Woolf E; Verhaeghe T; Hughes N; Behling A; Brown K; Bulychev A; Buonarati M; Cherry E; Cho SJ; Cludts I; Dillen L; Dodge R; Edmison A; Garofolo F; Green R; Haidar S; Hottenstein C; Ishii-Watabe A; Jang HG; Ji A; Jones B; Kassim S; Ma M; Lima Santos GM; Norris DA; Owen T; Piccoli S; Ramanathan R; Röhl I; Rosenbaum AI; Saito Y; Sangster T; Savoie N; Stebbins C; Sydor J; de Merbel NV; Verthelyi D; Vinter S; Whale E
    Bioanalysis; 2018 Nov; 10(22):1781-1801. PubMed ID: 30488725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: A review of recent advances and future perspectives.
    Todoroki K; Mizuno H; Sugiyama E; Toyo'oka T
    J Pharm Biomed Anal; 2020 Feb; 179():112991. PubMed ID: 31761377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioanalytical strategy for the characterization and bioanalysis of biologics: a global, nonregulated bioanalytical lab perspective.
    Sarvaiya H; Niu S; Ladror DT; Wang Y; Maji D; Wolke M; Natarajan P; Jenkins GJ
    Bioanalysis; 2023 Feb; 15(3):133-148. PubMed ID: 36891956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2.
    Faria M; Peay M; Lam B; Ma E; Yuan M; Waldron M; Mylott WR; Liang M; Rosenbaum AI
    Antibodies (Basel); 2019 Jan; 8(1):. PubMed ID: 31544817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).
    Gupta S; Richards S; Amaravadi L; Piccoli S; Desilva B; Pillutla R; Stevenson L; Mehta D; Carrasco-Triguero M; Neely R; Partridge M; Staack RF; Zhao X; Gorovits B; Kolaitis G; Sumner G; Stubenrauch KG; Zou L; Amur S; Beaver C; Berger I; Berisha F; Birnboeck H; Bower J; Cho SJ; Cludts I; Cocea L; Donato LD; Fischer S; Fraser S; Garofolo F; Haidar S; Haulenbeek J; Hottenstein C; Hu J; Ishii-Watabe A; Islam R; Jani D; Kadavil J; Kamerud J; Kramer D; Kurki P; MacMannis S; McNally J; Mullan A; Papadimitriou A; Pedras-Vasconcelos J; Ray S; Safavi A; Saito Y; Savoie N; Fjording MS; Scheibner K; Smeraglia J; Song A; Stouffer B; Tampal N; der Strate BV; Verch T; Welink J; Xu Y; Yang TY; Yengi L; Zeng J; Zhang Y; Zhang Y; Zoog S
    Bioanalysis; 2017 Dec; 9(24):1967-1996. PubMed ID: 29205064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalysis of Oligonucleotide by LC-MS: Effects of Ion Pairing Regents and Recent Advances in Ion-Pairing-Free Analytical Strategies.
    Liu A; Cheng M; Zhou Y; Deng P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.
    Li P; Gong Y; Kim J; Liu X; Gilbert J; Kerns HM; Groth R; Rooney M
    Anal Chem; 2020 Aug; 92(15):10548-10559. PubMed ID: 32628461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application and challenges in using LC-MS assays for absolute quantitative analysis of therapeutic proteins in drug discovery.
    Zheng J; Mehl J; Zhu Y; Xin B; Olah T
    Bioanalysis; 2014 Mar; 6(6):859-79. PubMed ID: 24702115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC/MS/MS Bioanalysis of Protein-Drug Conjugates-The Importance of Incorporating Succinimide Hydrolysis Products.
    Shi C; Goldberg S; Lin T; Dudkin V; Widdison W; Harris L; Wilhelm S; Jmeian Y; Davis D; O'Neil K; Weng N; Jian W
    Anal Chem; 2018 Apr; 90(8):5314-5321. PubMed ID: 29589741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates.
    Mou S; Huang Y; Rosenbaum AI
    Antibodies (Basel); 2018 Nov; 7(4):. PubMed ID: 31544891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical LC-MS of therapeutic oligonucleotides.
    van Dongen WD; Niessen WM
    Bioanalysis; 2011 Mar; 3(5):541-64. PubMed ID: 21388267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIOANALYSIS AND BIOTRANSFORMATION OF OLIGONUCLEOTIDE THERAPEUTICS BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY.
    Sutton JM; Kim J; El Zahar NM; Bartlett MG
    Mass Spectrom Rev; 2021 Jul; 40(4):334-358. PubMed ID: 32588492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS bioanalysis of intact proteins and peptides.
    Kang L; Weng N; Jian W
    Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocapture LC-MS methods for pharmacokinetics of large molecule drugs.
    Werth EG; Roos D; Philip ET
    Bioanalysis; 2024 Apr; 16(7):165-177. PubMed ID: 38348660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalysis in the Age of New Drug Modalities.
    Shi J; Chen X; Diao J; Jiang L; Li L; Li S; Liang W; Jin X; Wang Y; Wong C; Zhang XT; Tse FLS
    AAPS J; 2021 May; 23(3):64. PubMed ID: 33942188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.